Search clinical trials for: PA-824

Total 1442 results

Universitätsklinikum Hamburg-Eppendorf

Completed

Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke (WAKE-UP)

Stroke

Germany, United Kingdom, Belgium, Denmark, France, Spain
RenJi Hospital

Completed

EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction (EARLY-MYO)

Acute ST-segment Elevation Myocardial Infarction

China
Central Hospital, Nancy, France

Terminated

Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke (THRACE)

Cerebrovascular Accident | Cerebral Stroke

France
Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.

Recruiting

Open-Label of SPN-820 in Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg

Hypertension

Korea, Republic of
OBI Pharma, Inc

Completed

Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects

Metastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Gastric Cancer

Taiwan
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)

Type 2 Diabetes Mellitus
Artax Biopharma Inc
Simbec Research; ORION Clinical Services; Packaging Coordinators Inc; Centro de...

Completed

Safety Study of Immune System Modulator for Autoimmune Diseases

Healthy Volunteers

United Kingdom
Wageningen University

Suspended

The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis Patients (CUPIDO)

Ulcerative Colitis

Netherlands
Boehringer Ingelheim

Completed

Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers

Healthy
Chong Kun Dang Pharmaceutical

Unknown

Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

Hypertension | Dyslipidemias

Korea, Republic of
Boehringer Ingelheim

Completed

Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)

Arthritis, Rheumatoid
Cochlear
Mayo Clinic; University of Iowa; NYU Langone Health; Ohio State University; University... and other collaborators

Completed

Nucleus Hybrid L24 Extended Duration Post Approval Study (HED)

Hearing Loss
Canopy Growth Corporation
James Madison University

Terminated

CHI-907 CBD Extract and Experiences of Test Anxiety

Anxiety

United States
Travere Therapeutics, Inc.

Terminated

Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants (PKAN)

Pantothenate Kinase-Associated Neurodegeneration

United States, Canada, Czechia, France, Germany, Italy, Norway, Poland, Spain
Merck Sharp & Dohme LLC

Terminated

Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)

Solid Tumors
Toray Industries, Inc

Completed

TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus

Uremic Pruritus

Bulgaria, Germany
Maastricht University Medical Center

Completed

The Effects of the Synbiotic Ecologic 825/scFOS on Intestinal Barrier Function and Immune Modulation (CRIB)

Healthy Volunteers

Netherlands
Boehringer Ingelheim

Completed

The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma

Asthma
Boehringer Ingelheim

Completed

Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
University of California, San Diego
The University of Texas Health Science Center, Houston; National Institute...

Terminated

The Intravascular Cooling in the Treatment of Stroke 2/3 Trial (ICTuS2/3)

Stroke, Acute

United States, Austria, Switzerland
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828

Hypertension

Korea, Republic of
Cochlear

Completed

Hybrid L24 New Enrollment Post Approval Study (HNE)

High Frequency Sensorineural Hearing Loss

United States
GTx

Completed

Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence (ASTRID)

Stress Urinary Incontinence

United States
MedImmune LLC

Withdrawn

A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants

Wheezing
Roswell Park Cancer Institute

Recruiting

Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial

Head and Neck Squamous Cell Carcinoma

United States
Medical College of Wisconsin

Completed

t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection (TOPCAT)

Central Venous Catheter Thrombosis | Central Venous Catheter Associated Bloodstream Infection

United States
Beijing Chao Yang Hospital

Completed

Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China

Thromboembolism | Pulmonary Embolism

China
Bausch Health Americas, Inc.

Terminated

AMG 827 in Subjects With Psoriatic Arthritis

Psoriatic Arthritis

United States, Canada
Oswaldo Cruz Foundation
World Health Organization; UNITAID

Not yet recruiting

Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro

Hepatitis C

Brazil
University of South Florida
CSL Behring

Completed

Subcutaneous Immunoglobulin for CIDP (SCIG)

Chronic Inflammatory Demyelinating Polyneuropathy

United States
Kiminori Kimura, MD
Japan Agency for Medical Research and Development; Ohara Pharmaceutical Co....

Completed

Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)

Liver Cirrhosis, Biliary | Primary Biliary Cholangitis (PBC)

Japan
Kiminori Kimura, MD
Japan Agency for Medical Research and Development

Recruiting

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

Liver Cirrhosis

Japan
Johns Hopkins University

Completed

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

Cerebral Hemorrhage

United States
GTx

Withdrawn

Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence

Stress Urinary Incontinence

United States
University of the Balearic Islands
Fundació La Marató de TV3

Unknown

Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity (FLIPAN)

Non Alcoholic Fatty Liver Disease

Spain
Johns Hopkins University
University of Cape Town

Completed

Assessing PA-824 for Tuberculosis (the APT Trial)

Pulmonary Tuberculosis

South Africa
Boundless Bio

Recruiting

Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications (STARMAP)

Solid Tumor

United States
Inipharm Australia Pty Ltd

Recruiting

A Study of INI-822 in Healthy Volunteers and Participants With Non-alcoholic Steatohepatitis (NASH) or Presumed NASH

Non-alcoholic Steatohepatitis

Australia
Bayer
Nerre Therapeutics Ltd.

Completed

A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms (SWITCH-1)

Hot Flashes | Menopause | Night Waking

United States, Canada, United Kingdom
Bayer

Completed

A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years

Hot Flashes | Healthy Volunteers | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

China
SK Chemicals Co., Ltd.
Toray Industries, Inc

Completed

Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis (TRK-820)

Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis

Korea, Republic of
Quadram Institute Bioscience

Completed

Effect of Apple Flavanols on Risk of Cardiovascular Disease (FLAVO)

Cardiovascular Disease

United Kingdom
ADARx Pharmaceuticals, Inc.

Recruiting

Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Hereditary Angioedema

Australia
University of Wuerzburg
Deutsche Krebshilfe e.V., Bonn (Germany)

Recruiting

I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer (CLERAD-PROBE)

Differentiated Thyroid Carcinoma

Germany
GTx

Completed

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

Non-Small Cell Lung Cancer | Muscle Wasting

United States
Kiminori Kimura, MD
Japan Agency for Medical Research and Development; Ohara Pharmaceutical Co....

Completed

Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV With Hemophilia.

Liver Cirrhosis

Japan
Boehringer Ingelheim

Completed

Safety, Tolerability, Biological Effects and Pharmacokinetics of BIIL 284 BS in Healthy Males

Healthy
MedImmune LLC

Completed

Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children

Respiratory Syncytial Virus Infections

United States, France, Spain, Denmark, Australia, New Zealand, Israel, United Kingdom, Italy, Sweden, Germany, Hungary, Chile, Argentina, Austria, Brazil, Bulgaria, Canada, Czech Republic, Greece, Iceland, Poland, Russian Federation, ...
B. Braun Medical Inc.

Terminated

Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy

Complications Associated With Device

United States

Search clinical trials for: PA-824

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations